http://www.fpnotebook.com/
Uterine Fibroid
Aka: Uterine Fibroid, Uterine Leiomyoma, Uterine Myoma- Epidemiology
- Most common solid pelvic tumor in women
- More common in non-white women
- Risk factors: Positive (increased risk of fibroids)
- Overweight women (increased Body Mass Index)
- Advancing age
- Hyperestrogenic states or Estrogen agonist use
- Enlarge in pregnancy (and regress after Menopause)
- Black women with higher Incidence
- Larger fibroids
- More symptomatic fibroids
- Comorbid Hypertension
- Family History of Uterine Fibroids
- Nulliparity
- Risk Factors: Negative (lower risk of fibroids)
- Five pregnancies or more
- Menopause (fibroids typically regress)
- Oral Contraceptive or Depo Provera use
- Tobacco Abuse
- Pathophysiology
- Benign tumors arising from myometrial smooth muscle
- Malignant leiomyosarcoma is uncommon (0.23%)
- Hormonally mediated
- Enlarge with Estrogen and Growth Hormone
- Regress with Progesterone
- Types of leiomyoma
- Subserosal leiomyoma
- Intramural leiomyoma
- Submucous leiomyoma
- Benign tumors arising from myometrial smooth muscle
- Symptoms (20-50% of fibroid disease is symptomatic)
- Symptoms with fibroids: Well supported by literature
- Menorrhagia (prolonged or heavy menstrual flow)
- Fibroids are most common cause of Menorrhagia
- Pelvic pressure or Pain Sensation (large fibroids)
- Pelvic discomfort
- Urine symptoms
- Constipation
- Exacerbated by pregnancy (see below)
- Menorrhagia (prolonged or heavy menstrual flow)
- Symptoms with fibroids: Controversial
- Infertility
- Pregnancy complications
- Recurrent Miscarriage
- Premature labor
- Fetal Malpresentation
- Labor complications
- Placental Abruption
- Symptoms with fibroids: Well supported by literature
- Signs
- Abdominal exam
- Uterus palpable above symphysis pubis
- Bimanual examination
- Enlarged, mobile and irregular uterine contour
- Abdominal exam
- Differential Diagnosis
- Adenomyoma
- Malignant Leiomyosarcoma (0.23% of fibroids)
- Diagnostics
- Transvaginal Ultrasound
- Best initial test due to cost efficacy
- Least Test Sensitivity and Specificity
- Pelvic MRI
- Best for fibroid mapping preoperatively
- Expensive
- Sonohysterography or hysteroscopy
- Good Test Sensitivity and Specificity, but invasive
- Transvaginal Ultrasound
- Management: Surgery
- Hysterectomy
- Fibroids account for up to 33% of hysterectomies
- Indications
- Postmenopausal women with enlarging fibroids
- Peristent Abnormal Uterine Bleeding
- Symptomatic fibroids refractory to other measures
- Myomectomy
- Performed with hysteroscopy, laparoscopy, robotic-assisted or laparotomy
- Excision of fibroids with preservation of Uterus
- High risk of recurrence (15-30% in 5 years)
- Indications
- Submucosal Fibroids in women who want to preserve fertility (hysteroscopic)
- Uterine Fibroid Embolization
- Myolysis
- Fibroid destruction by Nd-YAG laser or bipolar needle
- Often combined with endometrial ablation
- Recurrence rate not yet established
- Indications
- Fibroids in women who want to preserve fertility
- Hysterectomy
- Management: Medical
- Observation (preferred for asymptomatic cases)
- GnRH agonists (induce hypoestrogenism)
- Results in Amenorrhea and fibroid mass reduction
- Fibroids recur when medication stopped
- Hypoestrogenic side effects (Hot Flushes, BMD risk)
- Used in combination with Progesterone
- Reduces Hot Flushes (vasomotor symptoms)
- Progesterone receptor-binder (Mifepristone)
- Mifepristone 5 mg daily
- Other investigational measures
- Raloxifene (Evista)
- ExAblate 2000
- Uses combination of Ultrasound and MRI
- Focused coagulation necrosis of fibroids
- Agents effective in Menorrhagia but are not typically effective at reducing fibroid size
- Androgenic agents (e.g. Danazol)
- Levonorgestrel IUD
- Progestins (e.g. Depo Provera)
- Oral Contraceptive cycling (not effective)
- Tranexamic Acid (Lysteda)
- References
- Stewart (2012) Mayo POIM Conference, Rochester
- Evans (2007) Am Fam Physician 75:1503-8
- Myers (2002) Obstet Gynecol 100:8-17
- Rackow (2006) Gynecol Clin North Am 33:97-113